NCT07277972 2025-12-11Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic TherapyTianjin Medical University Cancer Institute and HospitalPhase 2 Not yet recruiting36 enrolled